Overview
Vesalius Therapeutics develops drugs for common diseases using its ContinuumDiscovery platform. The platform combines data science, artificial intelligence, and machine learning to identify distinct patient subgroups and the combined effects of multiple genes, then finds optimal drug targets to reverse disease in those groups. It also uses proprietary patient-derived, cell-based models to screen and characterize drug candidates. Unlike traditional approaches that treat common diseases as single conditions, Vesaliusus views them as a collection of genetically and biologically different subtypes, and it targets these unique characteristics with tailored drug development. The company aims to develop and commercialize novel therapies that address these genetic and biological differences to improve patient outcomes.
Work here?Claim your company